Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;12(3):1779-1782.
doi: 10.3892/ol.2016.4903. Epub 2016 Jul 22.

HPV strain distribution in patients with genital warts in a female population sample

Affiliations

HPV strain distribution in patients with genital warts in a female population sample

Daniel Boda et al. Oncol Lett. 2016 Sep.

Abstract

The incidence of human papillomavirus (HPV) in the human cancer domain is still a subject of intensive study. In this study, we examined cervical swab samples from 713 females with genital warts, and tested the samples for high- and low-risk genital HPV. HPV genotyping was assessed using a Genotyping test that detects HPV by the amplification of target DNA using polymerase chain reaction and nucleic acid hybridization. In total, we detected 37 anogenital HPV DNA genotypes [6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73 (MM9), 81, 82 (MM4), 83 (MM7), 84 (MM8), IS39 and CP6108] and investigated the incidence of these genotypes in the patients with genital warts. We found differences in the distribution of high-/low-risk strains and the incidence of high-risk strains was found to occur mainly in females under 35 years of age. The data from our study suggest that a detailed oral, rectal and genital identification of high-risk strains should be performed to visualize the entire pattern of possible triggers of carcinogenesis.

Keywords: HPV genotyping; carcinogenesis; cervical cancer; genital warts.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Human papillomavirus (HPV) strain distribution in the investigated study population: percentage of strain type reported in all cases investigated.
Figure 2.
Figure 2.
Age distribution in the investigated group in terms of high/low and negative strain identification.
Figure 3.
Figure 3.
Age distribution among human papillomavirus high-risk strains.

References

    1. Škamperle M, Kocjan BJ, Maver PJ, Seme K, Poljak M. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22:1–5. - PubMed
    1. Voidăzan S, Tarcea M, Morariu SH, Grigore A, Dobreanu M. Human papillomavirus vaccine - knowledge and attitudes among parents of children aged 10–14 years: A cross-sectional study, Tirgu Mures, Romania. Cent Eur J Public Health. 2016;24:29–38. doi: 10.21101/cejph.a4287. - DOI - PubMed
    1. Salavastru CM, Niculescu MC, Zota A, Nicola G, Morariu HS, Solovan C, Patrascu V, Popovici G, Vladuta R, Panduru M, et al. Epidemiological aspects of genital warts in romania - a 2012 retrospective survey. Maedica (Buchar) 2014;9:144–150. - PMC - PubMed
    1. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357–361. - PMC - PubMed
    1. Raţiu MP, Purcărea I, Popa F, Purcărea VL, Purcărea TV, Lupuleasa D, Boda D. Escaping the economic turn down through performing employees, creative leaders and growth driver capabilities in the Romanian pharmaceutical industry. Farmacia. 2011;59:119–130.

LinkOut - more resources